Indraprastha Medical Corporation Ltd
Incorporated in 1988 as a JV between Apollo Hospitals Enterprise Ltd. (AHEL) and the Delhi Government, Indraprastha Medical Corporation Ltd. is a super speciality tertiary care hospital in New Delhi. The Co. currently has 52 speciality departments. [1]
- Market Cap ₹ 2,133 Cr.
- Current Price ₹ 233
- High / Low ₹ 255 / 80.0
- Stock P/E 18.9
- Book Value ₹ 45.2
- Dividend Yield 1.29 %
- ROCE 34.3 %
- ROE 24.6 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company has delivered good profit growth of 31.7% CAGR over last 5 years
- Company has been maintaining a healthy dividend payout of 23.7%
Cons
- The company has delivered a poor sales growth of 7.86% over past five years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
522 | 607 | 678 | 714 | 755 | 766 | 753 | 788 | 831 | 613 | 888 | 1,099 | 1,204 | |
455 | 528 | 587 | 630 | 675 | 686 | 678 | 706 | 743 | 572 | 768 | 947 | 1,026 | |
Operating Profit | 67 | 79 | 91 | 85 | 80 | 79 | 74 | 82 | 87 | 41 | 120 | 152 | 178 |
OPM % | 13% | 13% | 13% | 12% | 11% | 10% | 10% | 10% | 11% | 7% | 14% | 14% | 15% |
1 | 1 | 1 | 1 | 1 | -0 | -1 | -1 | -0 | -0 | -3 | 9 | 17 | |
Interest | 6 | 9 | 10 | 8 | 7 | 8 | 9 | 7 | 6 | 3 | 3 | 4 | 3 |
Depreciation | 22 | 26 | 28 | 28 | 35 | 31 | 31 | 30 | 33 | 33 | 35 | 39 | 40 |
Profit before tax | 40 | 45 | 54 | 50 | 39 | 41 | 34 | 45 | 48 | 4 | 79 | 117 | 152 |
Tax % | 33% | 37% | 35% | 34% | 37% | 36% | 38% | 36% | 9% | 46% | 26% | 26% | |
27 | 29 | 35 | 32 | 24 | 26 | 21 | 28 | 44 | 2 | 59 | 86 | 113 | |
EPS in Rs | 2.95 | 3.14 | 3.87 | 3.54 | 2.66 | 2.86 | 2.30 | 3.10 | 4.76 | 0.25 | 6.39 | 9.40 | 12.28 |
Dividend Payout % | 54% | 51% | 47% | 51% | 68% | 63% | 65% | 52% | 0% | 0% | 39% | 32% |
Compounded Sales Growth | |
---|---|
10 Years: | 6% |
5 Years: | 8% |
3 Years: | 10% |
TTM: | 16% |
Compounded Profit Growth | |
---|---|
10 Years: | 12% |
5 Years: | 32% |
3 Years: | 25% |
TTM: | 38% |
Stock Price CAGR | |
---|---|
10 Years: | 19% |
5 Years: | 43% |
3 Years: | 60% |
1 Year: | 176% |
Return on Equity | |
---|---|
10 Years: | 15% |
5 Years: | 16% |
3 Years: | 17% |
Last Year: | 25% |
Balance Sheet
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 92 | 92 | 92 | 92 | 92 | 92 | 92 | 92 | 92 | 92 | 92 | 92 | 92 |
Reserves | 68 | 79 | 95 | 103 | 132 | 139 | 141 | 152 | 176 | 181 | 234 | 288 | 323 |
67 | 73 | 63 | 50 | 52 | 67 | 66 | 21 | 4 | 3 | 5 | 2 | 5 | |
175 | 194 | 199 | 196 | 185 | 160 | 134 | 157 | 177 | 157 | 131 | 173 | 248 | |
Total Liabilities | 402 | 438 | 449 | 442 | 460 | 458 | 432 | 422 | 449 | 432 | 462 | 555 | 668 |
234 | 300 | 293 | 286 | 301 | 296 | 294 | 280 | 303 | 283 | 277 | 275 | 280 | |
CWIP | 42 | 0 | 2 | 3 | 3 | 0 | 0 | 1 | 0 | 3 | 0 | 3 | 31 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
126 | 138 | 154 | 153 | 157 | 163 | 138 | 141 | 146 | 145 | 185 | 278 | 356 | |
Total Assets | 402 | 438 | 449 | 442 | 460 | 458 | 432 | 422 | 449 | 432 | 462 | 555 | 668 |
Cash Flows
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
55 | 67 | 58 | 64 | 62 | 28 | 48 | 75 | 86 | 27 | 94 | 144 | |
-28 | -54 | -22 | -29 | -33 | -22 | -30 | -17 | -40 | -19 | -74 | -108 | |
-27 | -13 | -36 | -35 | -30 | -5 | -17 | -44 | -43 | -3 | -3 | -26 | |
Net Cash Flow | 1 | 0 | 0 | -0 | -0 | -0 | 1 | 14 | 4 | 5 | 17 | 11 |
Ratios
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 23 | 32 | 35 | 40 | 41 | 47 | 41 | 35 | 35 | 40 | 18 | 23 |
Inventory Days | ||||||||||||
Days Payable | ||||||||||||
Cash Conversion Cycle | 23 | 32 | 35 | 40 | 41 | 47 | 41 | 35 | 35 | 40 | 18 | 23 |
Working Capital Days | -25 | -28 | -19 | -23 | 0 | 14 | 12 | -5 | -8 | 0 | -1 | -11 |
ROCE % | 20% | 23% | 26% | 23% | 18% | 17% | 15% | 19% | 21% | 3% | 29% | 34% |
Documents
Announcements
-
Compliance Certificate For The Year Ended 31St March, 2024
15 Apr - All certificates have been issued, for the financial year ended 31st march, 2024, within 30 days of the date of lodgment for transfer, sub-division, consolidation, …
-
Announcement under Regulation 30 (LODR)-Credit Rating
9 Apr - ICRA Limited has reaffirmed: a) long-term credit rating of [ICRA]AA (pronounced ICRA Double A) and short-term rating of [ICRA]A1+(pounced ICRA A one Plus) for Rs. …
-
Compliance Certificate For The Year Ended On 31St March,2024.
8 Apr - Compliance certificate for the period 1st April, 2023 to 31st March, 2024.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
8 Apr - Certificate dated 4th April, 2024, issued by M/s. Link Intime India Private Limited, Registrar & share Transfer Agent of the Company, for the quarter ended …
-
Clarification On Movement In Share Price
6 Apr - Of receipt of your email dated 5th April, 2024 seeking our clarification on increase in movement in price of shares of the Company across the …
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2012
from nse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2010
from nse
JV of Apollo
IMCL is a JV between Apollo Hospital (22%) and the State Government of Delhi (26%), and has presence in the NCR with two facilities, a 718-bedded facility in Sarita Vihar (operational since 1996) and a 46-bedded facility in Noida (since 2006). [1]